How do regulatory agencies address pediatric drug availability?
Regulatory agencies like the FDA and EMA have initiatives to encourage the study and development of pediatric medications. Programs such as the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) in the United States aim to increase the availability of safe and effective medications for children through incentives and requirements for pharmaceutical companies.
